Pyrexia, commonly known as fever, is a symptom often encountered in clinical practice. It is a complex physiological response to disease, often indicating an underlying infection. Understanding its pathophysiology and appropriate management strategies is paramount to providing effective patient care.
Pyrexia is a rise in the body's core temperature, typically above 38°C, as a result of an increase in the hypothalamic set point. It is generally triggered by pyrogens, substances that can originate either externally (exogenous) from infectious agents, or internally (endogenous) from inflammatory cytokines.
Diagnosis of pyrexia involves a detailed history, thorough physical examination, and targeted investigations. It's crucial to identify the cause of the fever, which may range from common infections to malignancies or autoimmune diseases. Laboratory tests, imaging studies, and microbiological cultures are often required to identify the source.
Management of pyrexia involves treating the underlying cause and providing symptomatic relief. Antipyretics, such as paracetamol and non-steroidal anti-inflammatory drugs (NSAIDs), are commonly used to alleviate discomfort. However, their use should be judicious, considering their potential side effects. In cases of severe or persistent fever, hospitalization may be necessary for further evaluation and treatment.
Fever is not merely a symptom but also a defense mechanism of the body. It enhances immune response and inhibits the growth of certain pathogens. However, prolonged or excessively high fever can cause deleterious effects, such as seizures or organ damage, emphasizing the importance of timely intervention.
Pyrexia is a common clinical manifestation with a broad differential diagnosis. It requires a systematic approach for effective management. By understanding its pathophysiology, identifying the cause, and implementing appropriate treatment strategies, clinicians can significantly improve patient outcomes and comfort.
1.
New guidelines for radiation therapy for HPV-associated head and neck cancer
2.
Cancer mortality continuing to decline, says report
3.
Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation
4.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
5.
Adding Targeted Agent to Perioperative Therapy for RCC May Improve Disease Control
1.
Different Types of Blood Dyscrasias
2.
Pembrolizumab Plus Lenvatinib in EBV-Associated Advanced Intrahepatic Cholangiocarcinoma: Case Study
3.
Lymphomatoid Papulosis: What You Need to Know
4.
MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed
5.
Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Clinical Insights in Oncology
2.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
3.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
4.
Navigating the Complexities of Ph Negative ALL - Part XI
5.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation